Healthcare
Longevity Health Holdings Inc.(XAGE)
Live Price
Offline$0.26
+0.00% today
1Y Change
-90.71%
Window
Jun 23, 2025 โ Jun 9, 2026
- Market Cap
- โ
- Revenue Growth
- +3701.4%
- EPS Growth
- -702.0%
- Dividend Yield
- 0.0%
Coverage: 242 bars ยท Jun 23, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Longevity Health Holdings Inc. (XAGE) is a Healthcare stock with listed on OTC. The stock last traded around $0.26 and down 90.7% across the available one-year price window (Jun 23, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +3701.4%, EPS growth of -702.0%, a dividend yield of 0.0%. What stands out right now is revenue +3701.4%, EPS -702.0%, free cash flow +23.8% with operating margin -371.6% and ROIC 135.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XAGE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+3701.4% vs +7.6% peer median
Operating Margin
Below sector median
-371.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 31, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +3701.4% and EPS is at -702.0%, with operating margin around -371.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 31, 2026 | โ | +0.0% | -8.5% | +6.1% |
2025 Nov 14, 2025 | โ | +1.3% | -7.2% | +3.4% |
2025 Aug 14, 2025 | โ | +8.5% | +8.1% | -18.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XAGE
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
XAGE Max Drawdown
-95.67%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for XAGE and SPY.
Company Overview
Longevity Health Holdings Inc.
Other OTC
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
- Leadership
- Janakiram Ajjarapu
- IPO Date
- Sep 23, 2021
- Employees
- 15
- Street Address
- 2403 Sidney Street
- Mailing
- Pittsburgh, PA, 15203
- Region
- Pittsburgh, PA, US
- Reporting Currency
- USD
- Investor Line
- 412 894 8248
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.2
- Price/Book
- โ
Growth
- Revenue
- +3701.4%
- EPS
- -702.0%
- Free Cash Flow
- +23.8%
Profitability
- Gross Margin
- 57.2%
- Operating Margin
- -371.6%
- Net Margin
- -361.0%
- ROE
- 158.9%
- ROIC
- 135.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.25
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.